Bright Competitors

Summary

BHGDelisted Stock

USD 12.29 0.39 3.08%

Bright Health Group competes with Alignment Healthcare, Molina Healthcare, Clover Health, Centene Corp, and CVS Health; as well as few others. The company runs under Health Care Equipment & Supplies sector within Health Care industry. Analyzing Bright Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bright Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bright Health competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
12.29	12.29	12.29

Details

Intrinsic

Valuation

Low	Real	High
11.36	11.36	13.52

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bright Health. Your research has to be compared to or analyzed against Bright Health's peers to derive any actionable benefits. When done correctly, Bright Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bright Health Group.

Bright Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bright Health and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Bright and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bright Health Group does not affect the price movement of the other competitor.

	ALHC	MOH	CLOV	CNC	CVS	HUM	CI	ELV	UNH
ALHC		-0.2	0.44	-0.58	-0.04	-0.52	-0.53	-0.62	0.14	ALHC
MOH	-0.2		-0.39	0.84	0.06	0.48	0.64	0.79	0.09	MOH
CLOV	0.44	-0.39		-0.47	0.39	-0.81	-0.6	-0.59	-0.37	CLOV
CNC	-0.58	0.84	-0.47		0.3	0.55	0.84	0.96	0.02	CNC
CVS	-0.04	0.06	0.39	0.3		-0.37	0.27	0.22	0.03	CVS
HUM	-0.52	0.48	-0.81	0.55	-0.37		0.61	0.65	0.29	HUM
CI	-0.53	0.64	-0.6	0.84	0.27	0.61		0.91	0.27	CI
ELV	-0.62	0.79	-0.59	0.96	0.22	0.65	0.91		0.1	ELV
UNH	0.14	0.09	-0.37	0.02	0.03	0.29	0.27	0.1		UNH
	ALHC	MOH	CLOV	CNC	CVS	HUM	CI	ELV	UNH

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

ELV	+ 0.96	CNC
ELV	+ 0.91	CI
CNC	+ 0.84	MOH
CI	+ 0.84	CNC
ELV	+ 0.79	MOH
ELV	+ 0.65	HUM

High negative correlations

HUM	- 0.81	CLOV
ELV	- 0.62	ALHC
CI	- 0.6	CLOV
ELV	- 0.59	CLOV
CNC	- 0.58	ALHC
CI	- 0.53	ALHC

Risk-Adjusted Indicators

There is a big difference between Bright Stock performing well and Bright Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bright Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ALHC	3.40	0.38	0.10	0.38	3.83	(3.71)	8.66	(4.65)	34.84
MOH	2.03	(0.18)	0.00	(3.89)	0.00	0.00	3.52	(3.81)	21.48
CLOV	3.57	0.08	0.02	0.19	4.87	(3.69)	7.94	(7.32)	44.77
CNC	1.71	(0.37)	0.00	(2.41)	0.00	0.00	2.38	(4.00)	12.57
CVS	1.70	(0.11)	(0.02)	0.05	2.44	(1.60)	3.57	(3.45)	18.70
HUM	2.05	(0.37)	0.00	(0.11)	0.00	0.00	3.69	(3.94)	14.35
CI	1.10	(0.15)	0.00	(0.14)	0.00	0.00	1.94	(2.89)	9.74
ELV	1.22	(0.52)	0.00	(0.56)	0.00	0.00	1.97	(2.93)	13.29
UNH	1.06	(0.05)	(0.03)	0.06	1.73	(1.07)	2.53	(1.90)	9.77

Unable to evaluate fundamental data of [ALHC, MOH, CLOV, CNC, CVS, HUM, CI, ELV, UNH] at this time. Please try again later

All Fundamental Data

Bright Health Competitive Analysis

The better you understand Bright Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bright Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bright Health's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	BHG	ALHC	MOH	CLOV	CNC	CVS	HUM	CI	ELV	UNH
	3.08 12.29 Bright	2.82 12.39 Alignment	2.47 297.97 Molina	3.56 3.49 Clover	1.76 61.43 Centene	3.57 60.08 CVS	2.04 304.18 Humana	1.39 333.01 Cigna	1.25 407.60 Elevance	2.53 605.83 UnitedHealth
Market Volatility (90 Days Market Risk)	Very steady	Slightly risky	Very steady	Dangerous	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady
Market Performance (90 Days Performance)	Very Weak	OK	Very Weak	Insignificant	Very Weak	Insignificant	Very Weak	Very Weak	Very Weak	Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Dangerous	Low	Low	Average	Very Low	Below Average	Low	Low	Low	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Fairly Valued	Over Valued	Under Valued	Under Valued	Under Valued	Fairly Valued	Under Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Strong Buy	Buy	Buy	Buy	Buy	Buy	Strong Buy	Strong Buy	Strong Buy
Trade Advice (90 Days Macroaxis Advice)	Not Rated	Sell	Cautious Hold	Strong Sell	Cautious Hold	Hold	Hold	Strong Hold	Cautious Hold	Hold
Current Ratio	0.87	3.1	1.45	1.29	1.06	0.94	1.53	0.83	1.35	0.78
Net Asset	4.67 B	591.88 M	14.89 B	570.67 M	84.64 B	249.73 B	47.06 B	152.76 B	108.93 B	273.72 B
Profit Margin	-0.58	-0.0584	0.0305	-0.0432	0.021	0.0137	0.0118	0.0132	0.0369	0.0364
EBITDA	(334.34 M)	(105.3 M)	1.74 B	(210.84 M)	2.93 B	13.74 B	4.93 B	9.99 B	10.49 B	32.52 B
Operating Margin	-0.21	-0.0275	0.0475	-0.0282	0.0296	0.0159	0.0266	0.0274	0.0439	0.0864
Current Valuation	1.25 B	2.21 B	10.36 B	1.42 B	30.51 B	148.63 B	44.53 B	119.54 B	113.81 B	598.41 B
Price To Book	0.95	20.73	3.57	4.94	1.12	1.01	2.09	2.2	2.16	5.9
Retained Earnings	(3.16 B)	(880.26 M)	3.89 B	(2.16 B)	12.04 B	61.6 B	27.54 B	41.65 B	31.75 B	95.77 B
Current Asset	N/A	N/A	177.56 M	N/A	3.6 B	30.38 B	2.76 B	13.51 B	N/A	31.64 B
Five Year Return	N/A	N/A	N/A	N/A	N/A	2.81	0.64	0.42	1.13	1.35
Beta	0.94	1.46	0.59	2.04	0.49	0.54	0.52	0.51	0.85	0.59
Number Of Employees	2.84 K	1.54 K	18 K	552	67.7 K	219 K	67.6 K	70.33 K	104.9 K	440 K
Shares Outstanding	7.98 M	191.7 M	57.2 M	412.08 M	504.86 M	1.26 B	120.41 M	278.15 M	231.92 M	920.28 M
Cash Flow From Operations	(2.27 B)	(59.19 M)	1.66 B	(115.87 M)	8.05 B	13.43 B	3.98 B	11.81 B	8.06 B	29.07 B
Annual Yield	N/A	N/A	N/A	N/A	N/A	0.0459	0.0119	0.0168	0.016	0.0139
Total Debt	303.95 M	170.79 M	2.38 B	4.66 M	17.83 B	79.39 B	11.66 B	31.48 B	25.12 B	62.54 B
Return On Equity	-1.19	-0.95	0.26	-0.29	0.12	0.067	0.0784	0.0761	0.16	0.15
Z Score	-0.37	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return On Asset	-0.0701	-0.1	0.069	-0.0566	0.0351	0.0237	0.0401	0.028	0.0584	0.0692
Number Of Shares Shorted	104.17 K	4.51 M	888.43 K	18.33 M	14.44 M	21.85 M	4.38 M	3.45 M	2.85 M	7.06 M
Book Value Per Share	-132.46	0.6	83.68	0.68	53.54	59.57	145.88	150.61	188.74	102.42
Current Liabilities	N/A	N/A	102.94 M	N/A	3.63 B	23.17 B	2.39 B	18.21 B	N/A	42.9 B
Total Asset	4.67 B	591.88 M	14.89 B	570.67 M	84.64 B	249.73 B	47.06 B	152.76 B	108.93 B	273.72 B
Debt To Equity	0.022	0.61	0.79	0.066	0.84	1.0	0.85	0.74	0.66	0.59
Short Ratio	1.17	2.77	1.11	2.08	2.31	1.65	1.2	2.1	1.44	2.2
Target Price	26.67	12.91	369.2	4.23	81.72	68.35	288.15	399.0	520.12	623.93
Last Dividend Paid	N/A	N/A	N/A	N/A	N/A	2.6	3.54	5.43	6.37	7.96
Shares Owned By Institutions	65.02	87.31	99.91	20.14	99.46	82.91	94.77	89.88	91.8	90.1
Market Capitalization	130.51 M	2.38 B	17.04 B	1.75 B	31.01 B	75.61 B	36.63 B	92.63 B	94.53 B	557.54 B
Price To Earnings To Growth	-0.01	0.39	-0.62	-0.08	0.62	2.28	1.39	0.8	0.76	1.64
Price To Earning	N/A	N/A	26.49	N/A	20.27	42.99	19.12	13.93	19.27	26.34
Price To Sales	0.0473	0.96	0.45	0.83	0.21	0.21	0.32	0.4	0.54	1.42
Net Income	(1.59 B)	(148.17 M)	1.09 B	(213.36 M)	2.7 B	8.37 B	2.49 B	5.16 B	5.99 B	22.38 B
Earnings Per Share	-136.21	-0.76	19.66	-0.19	5.79	3.94	11.45	10.56	27.47	15.39
Shares Owned By Insiders	4.93	5.16	1.13	5.33	0.27	0.11	0.21	1.59	0.1	0.23
Revenue	2.76 B	1.82 B	34.07 B	2.03 B	154 B	357.78 B	106.37 B	195.19 B	171.34 B	367.53 B
Working Capital	(118.06 M)	220.51 M	4.37 B	166.85 M	4.04 B	(11.33 B)	366.27 M	(4.7 B)	N/A	(20.62 B)
Cash And Equivalents	466.32 M	567.45 M	4.01 B	711.78 M	12.07 B	12.95 B	5.06 B	5.92 B	7.39 B	27.91 B
Cash Per Share	3.61	3.03	135.88	1.49	30.34	15.21	143.73	16.96	150.32	45.51
Gross Profit	205.79 M	184.28 M	3.93 B	126.19 M	24.47 B	53.46 B	17.18 B	22.98 B	40.11 B	79.62 B
Day Typical Price	12.36	12.33	296.93	3.48	61.36	59.75	306.94	332.74	406.96	603.56
Accumulation Distribution	0.0465	0.0476	0.0275	0.0312	0.0191	0.0232	0.0299	0.0151	0.0153	0.0243
Market Facilitation Index	0.59	0.6	8.28	0.11	1.18	1.4	9.37	5.07	6.25	14.83
Daily Balance Of Power	(0.66)	0.5667	0.8672	1.090909	0.8983	1.478571	0.6478	0.8994	0.808	1.008766
Period Momentum Indicator	(0.39)	0.34	7.18	0.12	1.06	2.07	6.07	4.56	5.05	14.96
Rate Of Daily Change	0.97	1.03	1.02	1.04	1.02	1.04	1.02	1.01	1.01	1.03
Day Median Price	12.4	12.3	296.41	3.47	61.32	59.59	308.32	332.61	406.65	602.42
Price Action Indicator	(0.30)	0.26	5.15	0.075	0.64	1.52	(1.10)	2.69	3.48	10.89
Coefficient Of Variation	2571.68	889.35	(2,016)	2597.26	(700.48)	3091.99	(1,878)	(2,307)	(446.14)	2272.64
Mean Deviation	7.03	3.4	2.03	3.57	1.71	1.7	2.05	1.1	1.22	1.06
Jensen Alpha	0.4146	0.3807	(0.18)	0.0821	(0.37)	(0.11)	(0.37)	(0.15)	(0.52)	(0.05)
Total Risk Alpha	(1.37)	(0.22)	(0.71)	(0.69)	(0.73)	(0.32)	(0.67)	(0.34)	(0.72)	(0.20)
Sortino Ratio	0.0361	0.0981	N/A	0.0181	N/A	(0.02)	N/A	N/A	N/A	(0.03)
Downside Variance	82.48	19.41	N/A	27.45	N/A	6.49	N/A	N/A	N/A	3.38
Standard Deviation	11.73	4.99	3.41	5.8	2.4	2.54	3.18	1.68	1.87	1.67
Kurtosis	8.63	3.78	12.96	9.61	3.7	5.85	5.76	5.94	12.79	9.08
Potential Upside	14.36	8.66	3.52	7.94	2.38	3.57	3.69	1.94	1.97	2.53
Treynor Ratio	1.68	0.3842	(3.89)	0.1929	(2.41)	0.0459	(0.11)	(0.14)	(0.56)	0.0649
Maximum Drawdown	79.64	34.84	21.48	44.77	12.57	18.7	14.35	9.74	13.29	9.77
Variance	137.54	24.87	11.64	33.62	5.76	6.44	10.14	2.82	3.5	2.8
Market Risk Adjusted Performance	1.69	0.3942	(3.88)	0.2029	(2.40)	0.0559	(0.10)	(0.13)	(0.55)	0.0749
Risk Adjusted Performance	0.0391	0.0944	(0.03)	0.0381	(0.10)	0.0317	(0.03)	(0.03)	(0.17)	0.0391
Skewness	1.94	0.6086	1.39	1.8	(1.48)	0.924	(0.77)	0.5113	(2.60)	(1.16)
Semi Deviation	8.33	3.83	N/A	4.87	N/A	2.44	N/A	N/A	N/A	1.73
Information Ratio	0.0279	0.0867	(0.09)	0.0163	(0.20)	(0.02)	(0.09)	(0.12)	(0.29)	(0.03)
Value At Risk	(14.29)	(4.65)	(3.81)	(7.32)	(4.00)	(3.45)	(3.94)	(2.89)	(2.93)	(1.90)
Expected Short fall	(8.17)	(3.71)	N/A	(3.69)	N/A	(1.60)	N/A	N/A	N/A	(1.07)
Downside Deviation	9.08	4.41	N/A	5.24	N/A	2.55	N/A	N/A	N/A	1.84
Semi Variance	69.33	14.65	N/A	23.68	N/A	5.96	N/A	N/A	N/A	2.99

Bright Health Competition Performance Charts

Five steps to successful analysis of Bright Health Competition

Bright Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bright Health Group in relation to its competition. Bright Health's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Bright Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bright Health's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bright Health Group, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bright Health position

In addition to having Bright Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Target Risk ETFs Thematic Idea Now

Target Risk ETFs

ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Risk ETFs theme has 32 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Risk ETFs Theme or any other thematic opportunities.

View All Next

Launch

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in Bright Stock

If you are still planning to invest in Bright Health Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bright Health's history and understand the potential risks before investing.

	Global Correlations Find global opportunities by holding instruments from different markets
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Money Managers Screen money managers from public funds and ETFs managed around the world

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC